- Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC). Daniel Bsteh, Jonathan Buckley, Scott Mitchell, et al. Journal of Clinical Oncology. Volume 43, Number 16_suppl. Meeting Abstract: 2025 ASCO Annual Meeting. May 28, 2025
- (Download PDF)
-
Products
Sectors
Categories
